AZAB MOHAMMAD
Insider CIK 1309653 · DRRX Director · XENE Director · LSTA Director · ASTX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2026-01-09 | 2026-01-13 | 30,456 | — | $0 | 104,925 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 2,750 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 7,000 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | U Tender | 2025-09-11 | 2025-09-12 | 6,000 | — | $0 | 0 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2025-01-09 | 2025-01-13 | 15,789 | — | $0 | 74,469 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2024-01-09 | 2024-01-11 | 19,480 | — | $0 | 58,680 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2023-12-19 | 2023-12-20 | 823 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2023-12-19 | 2023-12-20 | 3,497 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2023-12-19 | 2023-12-20 | 3,497 | $9.85 | $34.4K | 74,225 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2023-12-19 | 2023-12-20 | 823 | $9.85 | $8.1K | 70,728 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2023-06-02 | 2023-06-02 | 18,475 | — | $0 | 18,475 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2023-01-09 | 2023-01-11 | 20,000 | — | $0 | 39,200 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2022-12-12 | 2022-12-13 | 3,086 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2022-12-12 | 2022-12-13 | 3,086 | $2.68 | $8.3K | 69,905 | SEC↗ |
| LSTA LISATA THERAPEUTICS, INC. | A Award | 2022-09-15 | 2022-09-16 | 19,200 | $6.25 | $120.0K | 19,200 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2022-06-28 | 2022-06-29 | 18,000 | — | $0 | 18,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-24 | 2022-05-25 | 10,000 | $0.39 | $3.9K | 55,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-24 | 2022-05-25 | 5,000 | $0.39 | $1.9K | 35,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-24 | 2022-05-25 | 5,000 | $0.39 | $1.9K | 40,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-24 | 2022-05-25 | 5,000 | $0.38 | $1.9K | 45,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-24 | 2022-05-25 | 5,000 | $0.39 | $1.9K | 60,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-17 | 2022-05-18 | 8,900 | $0.42 | $3.7K | 28,200 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-17 | 2022-05-18 | 1,800 | $0.42 | $756 | 30,000 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-17 | 2022-05-18 | 9,300 | $0.42 | $3.9K | 19,300 | SEC↗ |
| DRRX DURECT CORP | P Buy | 2022-05-16 | 2022-05-18 | 10,000 | $0.38 | $3.8K | 10,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2021-12-15 | 2021-12-17 | 3,086 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2021-12-15 | 2021-12-17 | 3,086 | $3.67 | $11.3K | 66,819 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2021-06-15 | 2021-06-16 | 27,500 | — | $0 | 27,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2021-06-03 | 2021-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2021-01-04 | 2021-01-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2020-12-15 | 2020-12-15 | 3,086 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2020-12-15 | 2020-12-15 | 3,086 | $3.76 | $11.6K | 63,733 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2020-06-01 | 2020-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2019-12-16 | 2019-12-17 | 3,086 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2019-12-16 | 2019-12-17 | 3,086 | $3.56 | $11.0K | 60,647 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2019-09-16 | 2019-09-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | S Sale | 2019-09-13 | 2019-09-17 | 23 | $9.31 | $214 | 57,561 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2018-12-06 | 2018-12-10 | 3,086 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2018-12-06 | 2018-12-10 | 3,086 | $3.07 | $9.5K | 57,584 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2018-06-21 | 2018-06-22 | 10,288 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2018-06-21 | 2018-06-22 | 10,288 | $3.70 | $38.1K | 54,498 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2018-06-04 | 2018-06-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-11-15 | 2017-11-16 | 15,000 | $2.22 | $33.3K | 44,210 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-09-22 | 2017-09-25 | 8,000 | $2.95 | $23.6K | 29,210 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-09-21 | 2017-09-25 | 2,000 | $2.95 | $5.9K | 21,210 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-08-18 | 2017-08-21 | 6,312 | $2.90 | $18.3K | 19,210 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-08-17 | 2017-08-21 | 23 | $2.65 | $61 | 12,898 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2017-06-01 | 2017-06-02 | 3,500 | — | $0 | 3,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2016-12-01 | 2016-12-02 | 12,345 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | F Tax w/h | 2016-12-01 | 2016-12-02 | 4,408 | $7.80 | $34.4K | 12,875 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2016-12-01 | 2016-12-02 | 12,345 | $3.21 | $39.6K | 17,283 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2016-06-02 | 2016-06-03 | 3,500 | — | $0 | 3,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2015-12-11 | 2015-12-14 | 2,469 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2015-12-11 | 2015-12-14 | 2,469 | $5.22 | $12.9K | 4,938 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 3,086 | — | $0 | 3,086 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2015-01-08 | 2015-01-12 | 2,469 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2015-01-08 | 2015-01-12 | 2,469 | $4.98 | $12.3K | 2,469 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2014-11-04 | 2014-11-06 | 5,144 | — | $0 | 5,144 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 260,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 60,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 280,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 300,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | D To issuer deriv | 2013-10-11 | 2013-10-16 | 200,000 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | U Tender | 2013-10-11 | 2013-10-16 | 8,753 | — | $0 | 0 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | A Award deriv | 2012-12-06 | 2012-12-10 | 300,000 | — | $0 | 300,000 | SEC↗ |
| ASTX Astex Pharmaceuticals, Inc | A Award deriv | 2012-03-07 | 2012-03-09 | 200,000 | — | $0 | 200,000 | SEC↗ |